The biosynthesis of glycoconjugates requires the relevant glycosyltransferases and nucleotide sugars that can act as donors. Given the biological importance of posttranslational glycosylation, a facile, robust and cost-effective strategy for the synthesis of nucleotide sugars is highly desirable. In this study, we demonstrate the synthesis of nucleotide sugars from corresponding monosaccharides in a highly efficient manner via metabolic engineering, using an enzymatic approach. This method exploits L-fucokinase/guanosine 5′-diphosphate (GDP)-L-fucose (L-Fuc) pyrophosphorylase (FKP), a bifunctional enzyme isolated from Bacteroides fragilis 9343, which converts L-Fuc into GDP-L-Fuc via an L-Fuc-1-phosphate intermediate. Because L-Fuc and D-arabinose (D-Ara) are structurally similar, it is assumed that the biosynthesis of GDP-D-Ara in a recombinant Saccharomyces cerevisiae strain harboring the FKP gene can occur through a mechanism akin to that of GDP-L-Fuc via the salvage pathway. Thus, we reasoned that by exogenously supplying different monosaccharides structurally related to L-Fuc, it should be possible to produce the corresponding nucleotide sugars with this recombinant yeast strain, regardless of internal acquisition of nucleotide sugars through expression of additive enzymes in the de novo pathway.
Introduction
L-fucose [L-Fuc; 6-deoxy-L-galactose (L-gal)] is an essential component of various mammalian glycan structures. This sugar decorates N-and O-linked glycoproteins and glycolipids (Walz et al. 1990) or is covalently linked to specific serine or threonine residues of certain proteins (Harris and Spellman 1993) . Guanosine 5′-diphosphate (GDP)-L-Fuc serves as the donor for fucosyltransferases that attach the activated L-Fuc to glycoconjugates in the endoplasmic reticulum and Golgi apparatus. On the basis of the attachment site of L-Fuc transfer, fucosyltransferases are classified as α1,2, α1,3/4, α1,6 and protein O-fucosyltransferases (Ma et al. 2006) . Various functions in biological processes have been established for L-Fuc residues (Becker and Lowe 2003) . ABO blood group antigens are α1,2-fucosylated glycans (Greenwell 1997; Lloyd 2000) . α1,3-and α1,4-fucosylations are essential components of sialyl Lewis X (sLe x )-type and sialyl Lewis a-type glycans, respectively, which have roles as selectin ligands in inflammation (Lowe 1997) . Fucosylated glycans also have important roles in fertilization (Johnston et al. 1998; Mori et al. 1998) . The lack of α1,6-fucosylation on transforming growth factor-β1 receptors was found to be involved in severe growth retardation phenotypes of FUT8-null mice (Wang et al. 2005) . This report strongly indicates that the α1,6-fucosylation of Nglycans have important functions in various biological events. O-fucose residues (i.e. L-Fuc directly linked to the hydroxyl group of serine or threonine residues) are present on EGF domains of mammalian Notch receptors (Moloney et al. 2000; Rampal et al. 2005) . Notch receptors are a family of transmembrane signaling proteins with important roles in normal development of an organism, e.g. neurogenesis, angiogenesis and lymphoid development (Artavanis-Tsakonas et al. 1999; Halloran et al. 2000) . Fucosylation is also involved in programmed cell death, i.e. apoptosis (Hiraishi et al. 1993; Russell et al. 1998; Winkler et al. 2004) .
Fucosylation requires GDP-L-Fuc as a donor and as a substrate for fucosyltransferases. GDP-L-Fuc is synthesized via two different metabolic pathways in vivo, which both take place in the cytoplasm. The major de novo pathway is constitutively active and evolutionarily conserved. This pathway was first identified in bacteria (Ginsburg 1960) and then later in plants (Liao and Barber 1971) , mammals (Overton and Serif 1981) and invertebrates (Bulet et al. 1984) . The genes encoding the enzymes in the synthetic pathway have been cloned from several bacteria (Tonetti et al. 1998) , plants (Bonin et al. 1997 ) and mammals (Reitman et al. 1980) . Furthermore, the pathway has also been characterized in silico in Drosophila melanogaster (Roos et al. 2002) . The de novo pathway involves conversion of GDP-D-mannose (GDP-DMan) to GDP-L-Fuc via three enzymatic reactions catalyzed by two enzymes, GDP-D-Man-4,6-dehydratase (gmd, in human designated as GMD, EC 4.2.1.47) and GDP-4-keto-6-deoxy-D-Man-3,5-epimerase-4-reductase (Tsta3, in human designated as FX, EC 1.1.1.187; Tonetti et al. 1996 Tonetti et al. , 1998 Sullivan et al. 1998 ). In the first step, GMD converts GDP-DMan to an unstable intermediate, GDP-4-keto-6-deoxy-DMan, by a dehydration reaction. This enzyme reaction comprises an oxidation of a hydroxyl group at C-4 of D-Man to a keto group as well as a reduction in a hydroxyl group at C-6 of mannose to a methyl residue, which requires the cofactor nicotinamide adenine dinucleotide phosphate (NADP + ; Chang et al. 1985; Oths et al. 1990; Sullivan et al. 1998) . The enzyme cascade from GDP-D-Man to GDP-L-Fuc is inhibited by the final product (GDP-L-Fuc), as it is a potent competitive inhibitor of GMD (Sturla et al. 1997; Bisso et al. 1999) . Dual functional epimerase-reductase enzyme FX converts GDP-4-keto-6-deoxy-D-Man to GDP-L-Fuc (Chang et al. 1988; Tonetti et al. 1996) . In the first FX reaction, GDP-4-keto-6-deoxy-DMan is epimerized at C-3 and C-5, which causes a change from D-to L-configuration and yields GDP-4-keto-6-deoxy-LGal. The 4-reductase activity of the FX protein catalyzes an H + ion transfer from the nicotinamide adenine dinucleotide phosphate reduced H (NADPH) cofactor to a keto group yielding GDP-L-Fuc and NADP + (Menon et al. 1999) . GMD and FX transcripts are ubiquitously expressed in most human tissues (Sullivan et al. 1998) . A study of an induced mutation in the locus encoding mouse FX revealed the requirement for GDP-L-Fuc in fertility, growth and development as well as in leukocyte adhesion (Smith et al. 2002) . Fucosylated glycan deficiency can be corrected by supplementing the diet with L-Fuc, which restores the synthesis of GDP-L-Fuc through a normally quiescent salvage pathway (Smith et al. 2002) .
The enzymes, L-fucokinase (Fuk, EC 2.7.1.52) and GDP-LFuc pyrophosphorylase (Fpgt, EC 2.7.7.30), of the alternative "salvage" biosynthetic pathway of GDP-L-Fuc synthesis were first discovered in pig liver in the late 1960's ). In the GDP-L-Fuc salvage pathway, Fuk synthesizes L-Fuc-1-phosphate (L-Fuc-1-P) from L-Fuc and adenosine-5′-triphosphate Park et al. 1998) . The second step involves GDP-L-Fuc pyrophosphorylase, also designated as L-Fuc-1-P guanylyltransferase, which catalyzes the formation of GDP-L-Fuc from L-Fuc-1-P and guanosine 5′-triphosphate Pastuszak et al. 1998) . Free L-Fuc for the salvage pathway is obtained from the diet, or in the case of cultured cells from culture medium, and is transported across the plasma membrane into the cytoplasm. Furthermore, free L-Fuc can be obtained from intracellular degradation of glycoproteins and glycolipids in lysosomes by fucosidases (Michalski and Klein 1999) . Both Fuk (Park et al. 1998 ) and Fpgt activities ) have been detected in various tissues indicating that salvage metabolism is a common phenomenon in eukaryotes. Previous studies indicate that Fuk activity is regulated in response to stimulation of the brain by dopaminergic pathways and exposure of aortic endothelial cells to nicotine (Ricken et al. 1990; Hocher et al. 1993) .
There are currently two major strategies for the synthesis of GDP-L-Fuc; a chemical route and one involving enzymatic pathways. Various approaches have been used in the relatively complex chemical synthesis starting from L-Fuc with the end product being GDP-L-Fuc (Adelhorst and Whitesides 1993; Murray et al. 1997) . Enzymatic synthesis of GDP-L-Fuc can also be divided into two pathways: the predominant de novo route starting from GDP-D-Man and the minor salvage pathway using L-Fuc as the starting material (Becker and Lowe 1999) . The latter pathway has been successfully performed with purified enzymes in a recycling one-pot approach, but not with recombinant enzymes (Ichikawa et al. 1992 (Ichikawa et al. , 1994 . Furthermore, this salvage pathway can be utilized with the help of enzymes from a nonpathogenic protozoan Crithidia fasciculata (Mengeling and Turco 1999) , which expresses cytosolic D-Ara-1-kinase and D-Ara-1-P pyrophosphorylase activities. As well as being used for the synthesis of GDP-D-Ara from D-Ara, these enzymes can also be applied to the synthesis of GDP-L-Fuc using L-Fuc as a substrate even though C. fasciculata is not known to possess L-Fuc-containing molecules under normal physiological conditions (Mengeling and Turco 1999) .
The yeast S. cerevisiae is also an ideal host for the expression of de novo pathway enzymes for the synthesis of GDP-L-Fuc (Hirschberg et al. 1998 ). In the yeast cells, glycosylation is largely restricted to mannosylation, whereas L-Fuc metabolism has not been detected in these organisms (Romanos et al. 1992; Hashimoto et al. 1997) . Thus, the cytoplasm of yeast cells is a relatively rich source of GDP-D-Man, the starting material for the de novo pathway. Mattila et al. (2000) and Nakayama et al. (2003) introduced two genes encoding the de novo pathway enzymes GDP-D-Man-4,6-dehydratase (gmd or MUR1) and GDP-4-keto-6-deoxy-DMan-3,5-epimerase-4-reductase (wcaG or AtFX), derived from Escherichia coli and Arabidopsis thaliana, respectively, into S. cerevisiae. They then showed that these genes can be expressed in a functionally active form to synthesize GDP-L-Fuc from the endogenous GDP-D-Man. However, GDP-D-Man-4,6-dehydratase encoded by the gmd gene is competitively inhibited by GDP-L-Fuc. Moreover, the availability of endogenous GDP-D-Man is also a limiting factor for expressing any kind of de novo pathway genes. Thus, significant accumulation of GDP-L-Fuc cannot occur using this system.
Here, we report the in vivo synthesis of significant quantities of nucleotide sugars in the yeast cells using a bacterial enzyme. This method exploits Fuk/GDP-L-Fuc pyrophosphorylase (FKP), a bifunctional enzyme isolated from Bacteroides fragilis 9343, which converts fucose to L-Fuc-1-P and hence to GDP-L-Fuc (Coyne et al. 2005 ). This transformation is found in the salvage pathway of B. fragilis 9343 fucosylation and is conserved in all Bacteroides species (Coyne et al. 2005) . It is not known whether bacteria (Bacteroides) and Functional expression of L-fucokinase plants (Arabidopsis) can synthesize GDP-L-Fuc from L-Fuc via intermediate L-Fuc-1-P using this bifunctional enzyme (Kotake et al. 2008) . As revealed by a sequence alignment, the N-terminal domain (amino acids 1-430) of FKP shares 20% amino acid identity to the human GDP-L-Fuc pyrophosphorylase, while its C-terminal domain (amino acids 584-949) is similar to mammalian Fuks (Niittymaki et al. 2004) . Connecting these two domains is a 150-amino acid linker, whose function is currently unknown. Yi et al. (2009) demonstrated that the recombinant FKP from B. fragilis 9343, expressed in E. coli, is a promiscuous enzyme with relaxed specificity toward fucose analogs bearing different kinds of substituents at the C-5 position.
Because D-Ara and L-Fuc are structurally similar, it is reasonable to assume that the biosynthesis of GDP-D-Ara in S. cerevisiae harboring FKP can occur through a mechanism similar to that of GDP-L-Fuc biosynthesis via this salvage pathway. Here, we have developed a novel strategy for synthesizing nucleotide sugars in a recombinant yeast system. Specifically, we introduced FKP into S. cerevisiae and showed that this gene can be expressed to generate a functionally active enzyme that can synthesize nucleotide sugars from corresponding external monosaccharides. From the properties of the recombinant protein expressed in yeast, it can be inferred that the gene product has both Fuk and GDP-L-Fuc pyrophosphorylase activities. Loss-of-function mutant was used to confirm the physiological function of the gene product in the yeast system.
Results
Preparation of FKP and FKP ΔN gene constructs screening and protein expression of S. cerevisiae transformants Prokaryotes and eukaryotes employ two different metabolic pathways to synthesize GDP-L-Fuc, i.e. the de novo pathway or the salvage pathway (Ma et al. 2006) . We chose the B. fragilis salvage pathway ( Figure 1A ) to synthesize GDP sugars in yeast cells for two principal reasons. First, the final products in this pathway, GDP-L-Fuc and GDP-D-Ara, are not naturally produced in yeasts. Second, the structures and steps for biosynthesis of GDP-D-Ara in microbes and plants (Mengeling and Turco 1999; Linster et al. 2007) show similarity with the pathway of production of GDP-L-Fuc by the FKP enzyme. This metabolic capacity can be initiated by overexpression of the heterologous B. fragilis FKP gene.
The yeast cell lacks the relevant enzymes to generate GDP-L-Fuc by itself, thus making the monitoring of the functional expression of the transformed genes feasible (Romanos et al. 1992; Hashimoto et al. 1997) . Enzymatic activities for converting exogenous monosaccharides into GDP sugars are therefore absent in yeast cells. To facilitate this conversion, the following genes were cloned and expressed under the control of the triosephosphate dehydrogenase-3 (TDH3) promoter as follows. FKP that converts L-Fuc into GDP-L-Fuc, and the negative control FKP ΔN (FKP C-terminal portion, Fuk gene only) that converts L-Fuc into L-Fuc-1-P. FKP was fused to the gene encoding a triple influenza hemagglutinin epitope (3xHA) tag, whereas FKP ΔN was also fused to the 3xHA tag, in frame at the C-terminus of each open reading frame for easy detection of the recombinant proteins ( Figure 1B) . The control vector without any inserted genes (mock) or a single construct containing only FKP-3xHA or FKP ΔN-3xHA was introduced into yeast host strain, W303-1A. Several transformants of the host strain that were capable of surviving and proliferating on selective leucine deficient dropout plates were screened for stable integration of FKP and FKP ΔN genes.
Yeast cells of mock, FKP ΔN and FKP transformants were cultivated for 12 h. Total cell lysates (from 2 × 10 6 cells) were collected by rapid protein preparation, and then analyzed for production of the recombinant proteins using a monoclonal antibody against the 3xHA tag. Both gene products were clearly observed as shown in Figure 2 . As anticipated, a band of 43 kDa was detected for FKP ΔN and a 135 kDa band for FKP along with degradation products which were accompanied by an increase in the concentration of dithiothreitol (DTT). It is plausible that the instability occurred through chemical reduction in disulfide bonds of FKP protein, resulting in degradation ( Figure 2A ). In analogy to the result of FKP ΔN transformed yeast cells, the FKP ΔN band intensity was also decreased by raising DTT concentration ( Figure 2B) . No cross-reacting species were detected in the mock transformant control (data not shown).
Extraction and electrospray ionization quadrupole time-offlight mass spectrometry/mass spectrometry analysis of GDP-L-Fuc
To confirm the GDP-L-Fuc synthase activity in the cytoplasm of the yeast cells, we initially attempted to detect GDP-L-Fuc in the cell extract. Specifically, to verify the production of GDP-L-Fuc, we performed an analysis by mass spectrometry (MS). [M-H] − ion at m/z 588.078 corresponding to the ion of GDP-L-Fuc in the MS spectrum (Supplementary data, Figure S1 , arrow) was further subjected to MS/MS analysis ( Figure 3 ). The fragment ion at m/z 305 in MS/MS spectrum corresponds to the m/z value which lost guanosine from GDP-L-Fuc (Supplementary data, Table S1 ). The MS/MS result is compatible with that of GDP-L-Fuc standard (Supplementary data, Figure S2 ). Furthermore, the FKP transformed yeast culture without L-Fuc was examined in parallel to elucidate the background endogenous nucleotide sugars. GDP-L-Fuc nor GDP-D-Ara [M-H] − ions could not be detected in the cell extract derived from these cells (Supplementary data, Figure S3 ). As expected, GDP-L-Fuc was produced in the presence of L-Fuc, indicating that FKP is a functional enzyme for GDP-L-Fuc production in the yeast expression system.
Activity of GDP-L-Fuc synthase in vivo
Having demonstrated the anticipated function of the recombinant FKP in the salvage pathway, we next performed a quantitative analysis of the amount of GDP-L-Fuc produced in the FKP expressing yeast cells. Mono-Q HPLC (high-performance liquid chromatography) was used to purify the product. Our analysis revealed a significant peak at retention time 17.5 min in the sample derived from yeast cells expressing the FKP enzyme grown in the presence of L-Fuc (Supplementary data, Figure S4F , arrowhead). In contrast, only a faint peak at 17.5 min was detected when the same cells were grown in the absence of L-Fuc (Supplementary data, Figure S4C ). Both the Figure S5 ).
Higher resolution HPLC results were obtained by linearly increasing the concentration of 0.5 M KH 2 PO 4 up to 70% over 100 min. Using these conditions, the pure compound displayed a retention time of 31 min, which was identical to that of the product generated by yeast cells expressing the Figure 4A ). Quantitative analysis, using GDP-L-Fuc standard (25 nmol; Figure 4C ), confirmed that 230 nmol ( 0.135 mg) of GDP-L-Fuc is synthesized from 25 mL FKP transformed yeast cells (OD 600 1.0, 5 × 10 8 cells) with exogenous L-Fuc (15 mM) in the culture medium. This yield represents an 25-fold increase in comparison with previous work reported by Nakayama et al. (2003) in which the de novo pathway was introduced into yeast cells. These results indicate that FKP expressing yeast cells display no corresponding enzyme activity in the absence of exogenous L-Fuc. In contrast, the same cells grown in the presence of L-Fuc generated a significant amount of GDP-L-Fuc in vivo. Table S2 ). The obtained MS results show that GDP-D-Ara was produced in the yeast expression system. Unfortunately, however, the GDP-D-Ara compound is not commercially available so we were unable to determine the amount of GDP-D-Ara produced in the FKP transformed yeast cells by HPLC analysis. In principle, this strategy can be applied to other monosaccharide components, such as L-Gal. Studies are currently underway in our laboratory to demonstrate engineering of nucleotide sugars with L-Fuc analogs of different monosaccharides.
We show in this work that an exogenous promiscuous monosaccharide salvage pathway can functionally replace the corresponding de novo pathway for nucleotide sugar biosynthesis. The promiscuous nature of the salvage pathway can be exploited to allow incorporation of a variety of sugar analogs into polysaccharides, resulting in a highly homogeneous modification.
Discussion
The biosynthesis of GDP-L-Fuc, which acts as a nucleotide sugar donor for fucosylation, has received increased interest after the cloning, sequencing and expression of a number of α1,2-, α1,3/4-and α1,6-fucosyltransferase genes.
Furthermore, fucosylated glycans such as sLe x and/or Le x have been shown to play a crucial role in selectin-dependent extravasation of leukocytes and tumor cells as well as in bacterial and parasitic infections (Vestweber and Blanks 1999) . Currently, GDP-L-Fuc is a relatively expensive nucleotide sugar. Thus, laboratories working in the field of fucosylation would benefit enormously if this compound could be obtained more readily. Chemical synthesis of nucleotide sugars is a time-consuming process, generally requiring anhydrous chemical techniques, which are often beyond the methodological scope of the researcher who needs to use the nucleotide sugars. Commercial preparations of the commonly occurring nucleotide sugars are available, but tend to be very costly. Previous work has shown that E. coli/A. thaliana de novo pathway genes, gmd/MUR1 and wcaG/AtFX can be overexpressed in S. cerevisiae and that GDP-L-Fuc is synthesized when intracellular GDP-D-Man is provided (Mattila et al. 2000; Nakayama et al. 2003) . Our work offers a major improvement to this approach because only exogenous monosaccharide need be added to the culture medium of yeast cells expressing FKP. Here, we describe an inexpensive, rapid, simple method for preparing GDP-L-Fuc and GDP-D-Ara that used the standard biochemical techniques. We expressed B. fragilis 9343 enzyme, FKP in the cytoplasm of S. cerevisiae that catalyzes the biosynthesis of GDP sugars (Figure 6 ).
The amount of FKP protein (Fuk/GDP-L-Fuc pyrophosphorylase) was nearly six times higher than FKP ΔN (Fukonly) protein (Figure 2 , lane of 0 mM DTT). It is reasonable that in the FKP ΔN expressing yeast cells, degradation of FKP ΔN protein occurred through instability, resulting in loss of activity (L-Fuc-1-P was not observed, Supplementary data, Figure S4B and E), whereas when GDP-L-Fuc pyrophosphorylase (FKP N-terminal portion) was present in the vicinity of Fuk in the FKP expressing cells, L-Fuc was effectively converted to GDP-L-Fuc in vivo (Figure 4 and Supplementary data, Figure S4C and F). These results presented here suggest that the GDP-L-Fuc pyrophosphorylase protein (FKP N-terminal portion) may function to maintain Fuk protein (FKP C-terminal portion) in active form by stabilizing its conformation. Saccharomyces cerevisiae, a species of budding yeast, is non-infective to humans and therefore presents no associated health risks. In addition, S. cerevisiae grows rapidly at 30°C in cell culture medium and does not require serum or incubation with carbon dioxide. Furthermore, 25 mL culture ( 5 × 10 8 cells) provided more than 0.13 mg GDP-L-Fuc when cultured with 15 mM L-Fuc in the medium (Figure 4 ).
Our work also offers a simple and convenient strategy to produce GDP-D-Ara by adding D-Ara to the yeast cells expressing FKP enzyme. Furthermore, the S. cerevisiae FKPexpressing strain represents a major step toward the development of a "cell factory" for the production of GDP sugars, one of the most important specialty chemicals in glycobiology. Consequently, the enzymatic production of GDP sugars by a one-step transformation from external monosaccharides appears closer than ever.
The goal of producing GDP sugars in good yield has long been sought, but never achieved until now. The key to the success of our approach lies in three points: (i) the functional expression of the salvage pathway in the FKP transformed yeast strain has permitted direct uptake and conversion of exogenous monosaccharides from the medium in order to synthesize the corresponding nucleotide sugars; (ii) S. cerevisiae cells are quite tolerant to high concentrations of nucleotide sugars; and (iii) the L-Fuc structure is generally preserved during conversion by the salvage pathway. In addition, because yeast lack the de novo or salvage pathway for GDP-L-Fuc and GDP-D-Ara, the generation of natural GDP-sugar substrates are efficiently enhanced. In this case, the production of cytoplasmic nucleotide sugars exclusively relies on the monosaccharide produced by the salvage pathway. Therefore, highly homogenous preparations of nucleotide sugars can be obtained. Consequently, no complicated purification processes are required due to the high yield of nucleotide sugars and the lack of interference from GDP sugars in the host cell system.
In conclusion, we have shown that bacterial FKP gene can be expressed as a functional enzyme in S. cerevisiae. As a result, the yeast cells synthesize GDP-L-Fuc or GDP-D-Ara upon exogenous addition of L-Fuc or D-Ara, respectively. Moreover, the GDP sugars generated by this cost-and timeeffective routes can be further converted to bioactive glycosyl-oligosaccharide derivatives (e.g. Lewis' antigens) with relevant recombinant fucosyltransferases.
Materials and methods
Yeast strain and preparation of gene constructs Saccharomyces cerevisiae strain W303-1A (MATa leu2-3, 112 his3-11, 15 ade2-1 ura3-1 trp1-1 can1-100) was used for the in vivo synthesis of nucleotide sugars. Escherichia coli strain DH5α was used for the preparation and construction of plasmids. Saccharomyces cerevisiae cells were grown in yeast extract peptone adenine dextrose medium (2% Bacto peptone, 1% yeast extract, 2% glucose, 40 μg/mL adenine sulfate) or selective synthetic dropout [SD (-leu), 0.67% Bacto yeast nitrogen base without amino acids, 2% glucose and 0.69 g/L amino acid mixture lacking leucine] medium. Escherichia coli cells were grown in the Luria-Bertani broth (1% Bacto tryptone, 0.5% yeast extract, 0.5% NaCl, 0.2% glucose).
The FKP gene was polymerase chain reaction (PCR) amplified from B. fragilis 9343 (ATCC25285) chromosomal DNA and engineered into the unique EcoRI and XhoI sites of pCMV-Tag 2B vector (Stratagene, La Jolla, CA). After confirming that the amplification had not introduced any errors, FKP and a truncated version of the gene were subcloned into a yeast vector, YEp352GAP-II (Nakayama et al. 2003) , for 8 cells) were subjected to anion exchange chromatography using a Mono-Q column, and the GDP-L-Fuc fraction was isolated. After 5 min of sample injection, the ratio of 0.5 M KH 2 PO 4 was linearly increased up to 70 % over 100 min. The flow rate of buffers was 1 mL/min. W303-1A cells harboring an expression plasmid for FKP gene were grown in the absence (A) or the presence (B) of 15 mM L-Fuc. An aliquot (25 nmol) of GDP-L-Fuc standard was also injected onto the column (C). Yeast cells harboring the FKP gene grown in the presence of L-Fuc showed a peak corresponding to GDP-L-Fuc that was 9.25 times greater than the corresponding standard.
Functional expression of L-fucokinase expression. Specifically, the full length of FKP gene and the N-terminal truncated form, FKP ΔN (nucleotides 1752-2847), were amplified by PCR with the following primer pairs; 5′-GGAGCTCATGCAAAAACTACTATCTTTACCG-3′ and 5′-GCTCTAGACCCGGGTGATCGTGATACTTGGAATCCC-3′ for full length and 5′-GGAGCTCATTGTTTGGGGACGT AGC-3′ and 5′-GCTCTAGACCCGGGTGATCGTGATACTT GGAATCCC-3′ for the truncated form. Both PCR inserts were digested out with SacI and XbaI and introduced into the expression vector, YEp352GAP-II, which contains the TDH3 promoter. A 3xHA gene fragment was excised from pHA vector with SmaI and inserted into the SmaI site at the 3′-end of FKP and FKP ΔN. The gene fragment containing a TDH3 promoter, FKP-3xHA or FKP ΔN-3xHA and a TDH3 terminator was cut by BamHI and inserted into the BamHI site of pRS405 (Stratagene). The nucleotide sequence of each of these plasmid inserts was confirmed. The plasmids were then linearized by digestion with BstEII and integrated into the LEU2 locus of the yeast chromosome. All the restriction and modification enzymes used were from New England Biolabs (Hitchin, UK) or from Roche Diagnostics (Mannheim, Germany).
Transformation into S. cerevisiae
The pRS405 vector alone ( pRS405) or that containing either FKP-3xHA ( pRS405-FKP3xHA) or FKP ΔN-3xHA ( pRS405-FKPΔN3xHA) genes were used to transform the W303-1A yeast host strains by the method of Ito et al. (1983) . Transformants were selected using leucine dropout plates and confirmed by yeast colony PCR analyses.
Expression of B. fragilis proteins in yeast and western blot analysis
Several transformants growing on leucine dropout plates were picked and grown in 5 mL of SD (-leu) medium for 12 h at 30°C. The OD 600 was monitored and, as a general approximation, OD 600 1.0 corresponds to a cell count of 2 × 10 7 cells/mL. Cells were collected by centrifugation at 4000 × g for 5 min, washed twice with 1× phosphate-buffered saline (PBS) and 2 × 10 7 cells resuspended in 100 μL sample buffer [0.06 M Tris-HCl ( pH 6.8), 10% (v/v) glycerol, 2% (w/v) sodium dodecyl sulfate (SDS) and 0.25% (w/v) bromophenol blue] containing different concentrations of DTT (500, 200, 50 and 0 mM, end concentration). The samples were incubated at 95°C for 5 min and centrifuged at 14,000 × g for 5 min before loading the 10 µl aliquots of supernatants on a T-W Liu et al.
10% SDS-polyacrylamide gel electrophoresis (PAGE).
Proteins were electroblotted onto a polyvinylidene fluoride membrane (Millipore Corp., Billerica, MA) at 15 V for 1 h. After blocking, the HA antibody (Roche Diagnostics) was diluted in PBST (0.1% Tween 20) with 5% skimmed milk, and the membrane was incubated with HA antibody solution for 1 h at room temperature. Horseradish peroxidase-conjugated rabbit anti-mouse IgG (Zymax, South San Francisco, CA) was used as a secondary antibody and detected with ECL-enhanced chemiluminescence (GE Healthcare, Piscataway, NJ).
Extraction of nucleotide sugars
For intracellular nucleotide sugar extraction, yeast cell cultures of 25 or 50 mL SD (-leu) medium pH 7.5, containing 2 mM MgCl 2 in the absence or the presence of 15 mM monosaccharide (L-Fuc or D-Ara) were cultivated until OD 600 1.0 ( 5 × 10 8 or 1 × 10 9 cells). All strains (mock, FKP ΔN and FKP transformants) were grown in shake flasks at 32°C and 140 rpm, and the ratio of flask medium/volume was of 1/5. Cells were then harvested by centrifugation at 4000 × g for 5 min at 4°C, washed twice with five times volume of ice-cold distilled water and then resuspended in 4 mL of ice-cold 1 M formic acid containing 10% 1-butanol (v/v, a lipid solvent), pipetted gently and kept in ice water for 30 min. The supernatant was then cleared of cell debris by centrifugation at 6000 × g for 10 min at 4°C and dried by lyophilization. Each cell extract was then subjected to HPLC and MS analysis. For HPLC analysis, the dried sample was dissolved in 0.8 mL distilled water, and the nucleotide sugar fraction was isolated by Mono-Q column chromatography using SMART System (Amersham Pharmacia Biotech AB, Amersham, UK). The Mono-Q column was equilibrated with 10 mM KH 2 PO 4 at a flow rate of 1 mL/min. After 5 min of sample injection, the ratio of 0.5 M KH 2 PO 4 was linearly increased up to 100 or 70% over 40 or 100 min, respectively. The flow rate was maintained at 1 mL/min and the effluent was monitored with a UV detector at 254 nm. All the buffers were filtered through a 0.45 µm membrane filter before use. The amount of GDP-L-Fuc was calculated from peak areas by reference to an external standard (GDP-L-Fuc; Calbiochem, La Jolla, CA).
Analysis of nucleotide sugars by electrospray ionization quadrupole time-of-flight tandem MS FKP transformed cells were grown in 50 mL SD (-leu) medium ( pH 7.5) in the presence of 2 mM MgCl 2 and 15 mM L-Fuc or D-Ara until OD 600 1.0 at 32°C, and then pelleted. Formic acid (1 M) saturated with 1-butanol was added to the pellet, and cytoplasmic endogenous nucleotides, nucleotide sugars and excess GDP-L-Fuc or GDP-D-Ara were also extracted. The extracts were lyophilized to dryness and then analyzed using an ESI-quadrupole time of flight MS. All MS and MS/MS spectra were acquired in the negative ion mode using a micrOTOF-Q (Bruker Daltonics, Bremen, Germany) equipped with an ESI source. For sample preparation, the dried cell extract was dissolved in 0.5 mL distilled water and 1 μL of solution was then diluted in 50 μL with 50% methanol (v/v). Sample solution was infused at a flow rate of 8 μL/min using a syringe pump (Kd Scientific Inc., Holliston, MA). The ESI source was operated with a grounded capillary sprayer needle with the pressure of nitrogen nebulizing gas of 0.5 bar. The drying temperature and the drying gas flow rate were 180°C and 4 L/min, respectively. The capillary voltage was maintained at 3200 V with the end plate offset at 500 V.
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